NO20015480D0 - Mikrogranuler som ikke er löselige i magesyre, fremgangsmåter for å oppnå det samme og farmasöytiske preparater - Google Patents

Mikrogranuler som ikke er löselige i magesyre, fremgangsmåter for å oppnå det samme og farmasöytiske preparater

Info

Publication number
NO20015480D0
NO20015480D0 NO20015480A NO20015480A NO20015480D0 NO 20015480 D0 NO20015480 D0 NO 20015480D0 NO 20015480 A NO20015480 A NO 20015480A NO 20015480 A NO20015480 A NO 20015480A NO 20015480 D0 NO20015480 D0 NO 20015480D0
Authority
NO
Norway
Prior art keywords
microgranules
soluble
obtaining
methods
same
Prior art date
Application number
NO20015480A
Other languages
English (en)
Other versions
NO20015480L (no
NO331643B1 (no
Inventor
Bruno Criere
Pascal Suplie
Pascal Oury
Original Assignee
Ethypharm Lab Prod Ethiques
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9545866&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20015480(D0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Ethypharm Lab Prod Ethiques filed Critical Ethypharm Lab Prod Ethiques
Publication of NO20015480D0 publication Critical patent/NO20015480D0/no
Publication of NO20015480L publication Critical patent/NO20015480L/no
Publication of NO331643B1 publication Critical patent/NO331643B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO20015480A 1999-05-21 2001-11-08 Mikrogranuler som ikke er loselige i magesaft, fremgangsmater for a oppna det samme og farmasoytiske preparater NO331643B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9906479A FR2793688B1 (fr) 1999-05-21 1999-05-21 Microgranules gastroproteges, procede d'obtention et preparations pharmaceutiques
PCT/FR2000/001367 WO2000071121A1 (fr) 1999-05-21 2000-05-19 Microgranules gastroproteges, procede d'obtention et preparations pharmaceutiques

Publications (3)

Publication Number Publication Date
NO20015480D0 true NO20015480D0 (no) 2001-11-08
NO20015480L NO20015480L (no) 2002-01-10
NO331643B1 NO331643B1 (no) 2012-02-13

Family

ID=9545866

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20015480A NO331643B1 (no) 1999-05-21 2001-11-08 Mikrogranuler som ikke er loselige i magesaft, fremgangsmater for a oppna det samme og farmasoytiske preparater

Country Status (35)

Country Link
US (1) US8409612B1 (no)
EP (1) EP1178799B1 (no)
JP (2) JP5344781B2 (no)
KR (1) KR100603915B1 (no)
CN (1) CN1243546C (no)
AR (1) AR024036A1 (no)
AT (1) ATE247960T1 (no)
AU (1) AU771759B2 (no)
BG (1) BG65415B1 (no)
BR (1) BR0010832A (no)
CA (1) CA2373972C (no)
CZ (1) CZ302946B6 (no)
DE (1) DE60004815T2 (no)
DK (1) DK1178799T3 (no)
EA (1) EA003943B1 (no)
EE (1) EE04902B1 (no)
ES (1) ES2204598T3 (no)
FR (1) FR2793688B1 (no)
GE (1) GEP20053580B (no)
HK (1) HK1042851B (no)
HR (1) HRP20010940B1 (no)
HU (1) HU227590B1 (no)
IL (2) IL146484A0 (no)
IS (1) IS2160B (no)
MX (1) MXPA01011973A (no)
NO (1) NO331643B1 (no)
PL (1) PL198355B1 (no)
PT (1) PT1178799E (no)
RS (1) RS50241B (no)
SI (1) SI1178799T1 (no)
SK (1) SK287605B6 (no)
TR (1) TR200103325T2 (no)
UA (1) UA72522C2 (no)
WO (1) WO2000071121A1 (no)
ZA (1) ZA200109472B (no)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2821745B1 (fr) * 2001-03-09 2004-07-02 Ethypharm Lab Prod Ethiques Granules et granules enrobes au gout masque
FR2822704B1 (fr) * 2001-03-29 2005-02-18 Chiesi Sa Sels de cetoacides et d'acides amines gastroresistants et leur utilisation pour la preparation de medicaments
FR2845289B1 (fr) * 2002-10-04 2004-12-03 Ethypharm Sa Spheroides, procede de preparation et compositions pharmaceutiques.
ES2234393B2 (es) * 2003-04-29 2006-09-01 Laboratorios Belmac, S.A. "formulaciones de pelets de compuestos bencimidazolicos antiulcerosos y labiles al acido".
US8980894B2 (en) 2004-03-25 2015-03-17 Boehringer Ingelheim Vetmedica Gmbh Use of PDE III inhibitors for the treatment of asymptomatic (occult) heart failure
EP1579862A1 (en) 2004-03-25 2005-09-28 Boehringer Ingelheim Vetmedica Gmbh Use of PDE III inhibitors for the reduction of heart size in mammals suffering from heart failure
EP1920785A1 (en) 2006-11-07 2008-05-14 Boehringer Ingelheim Vetmedica Gmbh Liquid preparation comprising a complex of pimobendan and cyclodextrin
ES2924478T3 (es) 2012-03-15 2022-10-07 Boehringer Ingelheim Vetmedica Gmbh Formulación de comprimidos farmacéuticos para el sector médico veterinario, método de producción y uso de los mismos
EA034430B1 (ru) 2013-07-19 2020-02-06 Бёрингер Ингельхайм Ветмедика Гмбх Жидкая водная фармацевтическая композиция с консервантами, содержащая этерифицированные производные циклодекстрина
HUE056143T2 (hu) 2013-12-04 2024-01-28 Boehringer Ingelheim Vetmedica Gmbh Pimobendán javított gyógyászati készítményei
WO2016174664A1 (en) 2015-04-29 2016-11-03 Dexcel Pharma Technologies Ltd. Orally disintegrating compositions
US10537570B2 (en) 2016-04-06 2020-01-21 Boehringer Ingelheim Vetmedica Gmbh Use of pimobendan for the reduction of heart size and/or the delay of onset of clinical symptoms in patients with asymptomatic heart failure due to mitral valve disease
US10076494B2 (en) 2016-06-16 2018-09-18 Dexcel Pharma Technologies Ltd. Stable orally disintegrating pharmaceutical compositions

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4153677A (en) * 1978-05-18 1979-05-08 Sterling Drug Inc. Controlled-release composition
DK151608C (da) * 1982-08-13 1988-06-20 Benzon As Alfred Fremgangsmaade til fremstilling af et farmaceutisk peroralt polydepotpraeparat med kontrolleret afgivelse
GB8809421D0 (en) * 1988-04-21 1988-05-25 Fordonal Sa Antacid compositions with prolonged gastric residence time
JPH0768125B2 (ja) 1988-05-18 1995-07-26 エーザイ株式会社 酸不安定化合物の内服用製剤
US5654009A (en) * 1991-03-25 1997-08-05 Fujisawa Pharmaceutical Co., Ltd. Delayed action preparation
EP0520119A1 (de) * 1991-06-17 1992-12-30 Spirig Ag Pharmazeutische Präparate Neue orale Diclofenaczubereitung
US5681585A (en) * 1991-12-24 1997-10-28 Euro-Celtique, S.A. Stabilized controlled release substrate having a coating derived from an aqueous dispersion of hydrophobic polymer
FR2692146B1 (fr) 1992-06-16 1995-06-02 Ethypharm Sa Compositions stables de microgranules d'omeprazole gastro-protégés et leur procédé d'obtention.
WO1995025525A1 (en) * 1994-03-18 1995-09-28 Alfred Schmidt The use of dimeticone for the local antibacterial therapy and/or the prevention and therapy of helicobacter pylori (hp) associated syndromes and infectious diseases
SE9402431D0 (sv) * 1994-07-08 1994-07-08 Astra Ab New tablet formulation
GB2290965A (en) 1994-07-11 1996-01-17 Therapicon Srl Multiple layer capsules for drugs
US6113941A (en) * 1994-09-30 2000-09-05 Takeda Chemical Industries, Ltd. Substained release microcapsule of physiologically active compound which is slightly water soluble at pH 6 to 8
ES2094694B1 (es) * 1995-02-01 1997-12-16 Esteve Quimica Sa Nueva formulacion farmaceuticamente estable de un compuesto de bencimidazol y su proceso de obtencion.
SE9500422D0 (sv) * 1995-02-06 1995-02-06 Astra Ab New oral pharmaceutical dosage forms
US5708017A (en) 1995-04-04 1998-01-13 Merck & Co., Inc. Stable, ready-to-use pharmaceutical paste composition containing proton pump inhibitors
DE69628444T2 (de) 1995-09-21 2004-05-06 Pharma Pass Ii Llc, Irvine Säurelabile omeprazol enthaltende pharmazeutische zusammensetzung und verfahren zu dessen herstellung
JPH1029937A (ja) * 1996-05-15 1998-02-03 Kobayashi Seiyaku Kogyo Kk メフェナム酸水溶液製剤
ZA979937B (en) 1996-11-06 1999-05-18 Sharmatek Inc Delayed delivery system for acid-sensitive drugs
GB9710800D0 (en) * 1997-05-23 1997-07-23 Cipla Limited Pharmaceutical composition and method of preparing it
ES2137862B1 (es) * 1997-07-31 2000-09-16 Intexim S A Preparacion farmaceutica oral que comprende un compuesto de actividad antiulcerosa y procedimiento para su obtencion.
US6013280A (en) * 1997-10-07 2000-01-11 Fuisz Technologies Ltd. Immediate release dosage forms containing microspheres
DE69842173D1 (de) * 1997-12-08 2011-04-21 Nycomed Gmbh Neue Suppositoriumsform mit säureempfindlichem Wirkstoff
SE9704869D0 (sv) 1997-12-22 1997-12-22 Astra Ab New pharmaceutical formulaton II
SE9704870D0 (sv) 1997-12-22 1997-12-22 Astra Ab New pharmaceutical formulation I
FR2774288B1 (fr) * 1998-01-30 2001-09-07 Ethypharm Sa Microgranules d'omeprazole gastroproteges, procede d'obtention et preparations pharmaceutiques

Also Published As

Publication number Publication date
CZ20014155A3 (cs) 2002-04-17
BR0010832A (pt) 2002-03-05
MXPA01011973A (es) 2002-05-06
BG65415B1 (bg) 2008-07-31
IL146484A0 (en) 2002-07-25
HK1042851B (zh) 2004-01-30
HRP20010940B1 (en) 2004-10-31
ES2204598T3 (es) 2004-05-01
DK1178799T3 (da) 2003-12-22
CN1243546C (zh) 2006-03-01
KR100603915B1 (ko) 2006-07-24
SK16322001A3 (sk) 2002-05-09
HUP0201304A3 (en) 2007-11-28
ZA200109472B (en) 2002-08-07
RS50241B (sr) 2009-07-15
AR024036A1 (es) 2002-09-04
UA72522C2 (en) 2005-03-15
SI1178799T1 (en) 2003-12-31
CN1351494A (zh) 2002-05-29
DE60004815D1 (de) 2003-10-02
EE200100615A (et) 2003-02-17
JP2011157390A (ja) 2011-08-18
JP2003500358A (ja) 2003-01-07
HU227590B1 (hu) 2011-09-28
IS6151A (is) 2001-11-08
FR2793688B1 (fr) 2003-06-13
ATE247960T1 (de) 2003-09-15
PT1178799E (pt) 2004-01-30
TR200103325T2 (tr) 2002-05-21
NO20015480L (no) 2002-01-10
NO331643B1 (no) 2012-02-13
KR20020011990A (ko) 2002-02-09
PL198355B1 (pl) 2008-06-30
SK287605B6 (sk) 2011-03-04
JP5344781B2 (ja) 2013-11-20
EP1178799B1 (fr) 2003-08-27
IL146484A (en) 2006-04-10
EA200101221A1 (ru) 2002-04-25
US8409612B1 (en) 2013-04-02
HUP0201304A2 (en) 2002-08-28
AU771759B2 (en) 2004-04-01
CZ302946B6 (cs) 2012-01-25
HK1042851A1 (en) 2002-08-30
GEP20053580B (en) 2005-07-25
EE04902B1 (et) 2007-10-15
YU82301A (sh) 2004-07-15
CA2373972C (fr) 2011-07-12
WO2000071121A1 (fr) 2000-11-30
EA003943B1 (ru) 2003-10-30
FR2793688A1 (fr) 2000-11-24
HRP20010940A2 (en) 2003-02-28
WO2000071121A9 (fr) 2002-05-23
CA2373972A1 (fr) 2000-11-30
PL351658A1 (en) 2003-05-19
EP1178799A1 (fr) 2002-02-13
AU4765300A (en) 2000-12-12
IS2160B (is) 2006-11-15
BG106102A (en) 2002-07-31
DE60004815T2 (de) 2004-06-17

Similar Documents

Publication Publication Date Title
NO20013736D0 (no) Pyrazolkarboksylsyrederivater, deres fremstilling og farmasöytiske preparater inneholdende de samme
NO20014013L (no) 16-halogen-epotilonderivater, fremgangsmåter for fremstilling av disse og farmasöytisk anvendelse av dem
NO20002721L (no) Heterocykliske forbindelser for inhibering av mavesyresekresjon, fremgangsmÕter for deres fremstilling og farmasøytiske preparater derav
NO306253B1 (no) Arylsulfonyl-hydroksamsyre-derivater, anvendelse derav og farmasöytisk preparat
AU2001253167A1 (en) System and methods for group retirement plan administration
MA26800A1 (fr) Systemes et methodes aerosoles pour formulations pharmaceutiques.
NO985368L (no) Substituerte imidazolidinderivater, deres fremstilling, deres anvendelse og farmas°ytiske preparater inneholdende forbindelsene
NO20001409L (no) Karboksamidotiazolderivater, fremgangsmÕte for fremstilling derav og farmasøytiske blandinger
DK1202965T3 (da) Indolderivater, fremgangsmåde til fremstilling deraf, farmaceutiske præparater indeholdende disse og deres medicinske anvendelse
TR200000534A3 (tr) Bir ilacin uygulanmasi için metot ve sistem
NO20015480D0 (no) Mikrogranuler som ikke er löselige i magesyre, fremgangsmåter for å oppnå det samme og farmasöytiske preparater
WO2001028494A3 (en) Nordihydroguaiaretic derivatives for use in treatment of tumors
IS1864B (is) Nýjar bensímídasólafleiður sem vinna gegn magasári, aðferðir til að útbúa þær og lyfjablöndur sem innihalda þær
TR200002099A3 (tr) Siklobüten türevleri, bunlarin hazirlanmasi ve terapötik kullanimlari
NO20016247D0 (no) Streptograminderivater, deres fremstilling og preparater inneholdende derivatene
NO983472D0 (no) Taxoider, deres fremstilling og farmas°ytiske preparater inneholdende taxoidene
DK1210348T3 (da) Naphthyridinderivater, fremgangsmåde til deres fremstilling, deres anvendelse og farmaceutiske præparater omfattende dem
NO20013878L (no) (1-fenacy-3-fenyl-3-piperidylety)piperidinderivater, fremgangsmåte for fremstilling derav og farmasöytiske preparaterinneholdende de samme
NO20020777L (no) Farmasöytiske preparater inneholdende derivater og fremgangsmåte for fremstilling derav
HK1047037A1 (en) Pharmaceutical preparations containing nanosols ofchitosan, and their preparation.
DK1192163T3 (da) Dithiepino[6,5-b]pyriner, beslægtede præparater og fremgangsmåder
DK1183241T3 (da) Spiroimidazolidinderivater, deres præparation, deres anvendelse og farmaceutiske præparationer omfattende disse
IL146372A0 (en) Cinnamoylaminoalkyl-substituted benzenesulfonamide derivatives, processes for their preparation, their use and pharmaceutical preparations comprising them

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees